{
  "id": 18087615,
  "title": "2 cancer drugs from Li Ka-shing-backed Sequencio garner global attention",
  "url": "https://urgent.news/2026/11/04/2-cancer-drugs-from-li-ka-shing-backed-sequencio-garner-global",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T07:01:26.000Z",
  "source": {
    "name": "SCMP Business",
    "slug": "scmp-business",
    "url": "https://www.scmp.com/business/companies/article/3373234/2-cancer-drugs-li-ka-shing-backed-sequencio-garner-global-attention"
  },
  "original_language": "en",
  "account": null,
  "summary": "Two cancer vaccines from Hong Kong-based Sequencio Therapeutics have been selected for presentation at a major US conference, as companies bet on therapies based on ribonucleic acid (RNA) to deliver breakthroughs in cancer treatment. Sequencio, a subsidiary of Li Ka-shing-backed CK Life Sciences, said on Wednesday that it will present preclinical data on cancer vaccine candidates CKLS118 and…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}